Andrew Basham

Associate
San Francisco
  • 505 Montgomery Street
  • Suite 2000
  • San Francisco, CA 94111-6538
  • USA
Profile Experience

Andrew Basham advises private and public companies and private equity firms and their portfolio companies on strategic transactions, including acquisitions, dispositions, carve-outs, joint ventures, controlling and minority investments, growth equity, and general corporate matters.

Mr. Basham regularly advises clients across a range of industries, including:

  • Software
  • Internet and digital media
  • Healthcare and life sciences
  • Retail and consumer products

Mr. Basham’s public and private mergers and acquisitions and strategic transaction practice has included representation of numerous companies, including:

  • Alliance Data Systems on its approximately US$4.4 billion sale of its Epsilon business to Publicis Groupe
  • McKesson Corporation on its approximately US$800 million acquisition of Medical Specialties Distributors, LLC and on its approximately US$735 million acquisition of RXCrossroads from CVS Health Corporation*
  • Kohlberg Kravis Roberts & Co (KKR) on its joint venture and related transactions with FS Investments*
  • ACH Food Companies, Inc., a subsidiary of Associated British Foods, on its approximately US$365 million sale of their spices business to B&G Foods*
  • Computer Sciences Corporation on its approximately US$6 billion spin-off of CSRA and special dividend and the approximately US$2.3 billion merger of CSRA and SRA International*

*Matter handled prior to joining Latham

Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.